Session Details
[2PS-15]【J】Challenges of Experimental Virology to Prepare for the “Next Pandemic"
Thu. Dec 4, 2025 2:20 PM - 4:20 PM JST
Thu. Dec 4, 2025 5:20 AM - 7:20 AM UTC
Thu. Dec 4, 2025 5:20 AM - 7:20 AM UTC
Room 15(Pacifico Yokohama Conference Center 5F, 501)
Organizer: Kei Sato (The University of Tokyo), Takasuke Fukuhara (Kyushu University)
Five years have passed since the COVID-19 pandemic. The COVID-19 pandemic highlighted the threat of viral infections. However, as the WHO and CDC have suggested, COVID-19 is not the last pandemic in human history. Experimental virology" using molecular and cellular biology is essential to prepare for the risks of the "next pandemic". In this symposium we would like to discuss the importance of viral research based on molecular biology, which is necessary to prepare for the "next pandemic".
Introduction
[2PS-15-01]International collaboration to prepare for the next pandemic
○Kei Sato1 (1. The Institute of Medical Science, The University of Tokyo)
[2PS-15-02]Versatile Technologies for the Generation of Recombinant Viruses Essential for Phenotypic Analysis
○Tomokazu Tamura1,2 (1. Kyushu University, 2. Hokkaido University)
[2PS-15-03]Analysis of host factors involved in the severity of SARS-CoV-2 infection using a mouse model
○Chikako Ono1,2,3, Miwa Sasai1,2,3,4, Kosuke Takada2, Yasuhiro Kojima6,5, Shintaro Shichinohe2, Shuhei Taguwa1,2,3, Kentaro Uemura1,2,3, Sanae Ikehara7, Tokiko Watanabe1,2,3, Masahiro Yamamoto1,2,3,4, Eiryo Kawakami7,8,9, Teppei Shimamura5,10, Yuzuru Ikehara7, Yoshiharu Matsuura1,2,3 (1. Center for Infectious Disease Education and Research (CiDER), The Univ. of Osaka, 2. Research Institute for Microbial Diseases (RIMD), The Univ. of Osaka, 3. Center for Advanced Modalities and DDS (CAMaD), The Univ. of Osaka, 4. Immunology Frontier Research Center (IFReC), The Univ. of Osaka, 5. Medical Research Laboratory, Institute of Science Tokyo, 6. National Cancer Center Japan, 7. Graduate School of Medicine, Chiba University, 8. Institute for Advanced Academic Research, Chiba University, 9. RIKEN Information R&D and Strategy Headquarters (R-IH), RIKEN, 10. Graduate School of Medicine, Nagoya University)
[2PS-15-04]Linking Laboratory and Clinical Virology: Exploring Mucosal Antibody Correlates for Controlling Infectious Virus Shedding
○Sho Miyamoto1,2 (1. Department of Infectious Disease Pathology, National Institute of Infectious Diseases, Japanese Institute for Health Security, 2. Department of Infectious Disease Pathobiology, Chiba University)
[2PS-15-05]Clonotypic deciphering of T cell immunity for antiviral protection
○Xiuyuan Lu1, Sho Yamasaki1,2 (1. Laboratory of Molecular Immunology, Immunology Frontier Research Center, The University of Osaka, 2. Department of Molecular Immunology, Research Institute for Microbial Diseases, The University of Osaka)
[2PS-15-06(2P-785)]Genome-wide screening for host cell factors involved in Oz virus infection
○Yuta Homma1,3, Nanami Yamamoto2,3, Hideki Tani4, Haruhiko Isawa3, Kohji Noguchi2,3, Masayoshi Fukasawa3,2, Toshiyuki Yamaji1,3 (1. Fac. Pharm., Juntendo Univ., 2. Grad. Sch. Pharm Sci., Tokyo Univ. Sci., 3. Nat. Inst. Infectious Diseases, JIHS, 4. Toyama Inst. Health)
[2PS-15-07(2P-779)]Mechanistic Investigation of LC-Plasma-Induced Innate Immune Memory
○CHANG TANG1, Reno Otuka1, Kenta Jounai1, Hiroshi Ishii2, Tetsuro Matano3 (1. Kirin Holdings Company, Limited., 2. Japan Insititute of Health Security, National Institute of Infectious Diseases, 3. Japan Insititute of Health Security, National Institute of Infectious Diseases)
[2PS-15-08(2P-739)]Coordinated control of infected-cell clearance and tissue repair by host immune modulator CD5L in viral infection
○Satoko Arai1, Natsumi Maehara1, Toru Miyazaki1 (1. The Institute for AIM Medicine)